Status:
COMPLETED
Colorectal Cancer Screening Using Stool DNA-based SDC2 Methylation Test
Lead Sponsor:
Kyung Hee University Hospital at Gangdong
Collaborating Sponsors:
Genomictree, Inc.
Conditions:
Colorectal Cancer
Colon Polyp
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
A study of colorectal cancer screening using stool DNA-based SDC2 methylation test
Eligibility Criteria
Inclusion
- Patient who agreed the clinical trial and signed informed consent
- High risk patient for colorectal cancer (family history of colorectal cancer, history of adenomatous polyp excision, inflammatory bowel disease \> 15 years, or history of hereditary colorectal cancer)
- Patient who scheduled to receive colonoscopy
- Stool \> 20g before bowel preparation for colonoscopy
Exclusion
- No high risk patient under 60 years
- History of colorectal cancer
- Stool \< 20g or sample after bowel preparation
- Diarrhea or liquid stool which cannot be evaluated
- Patient who is judged as not suitable for clinical trial including a psychiatric disorder by a physician
Key Trial Info
Start Date :
June 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
1210 Patients enrolled
Trial Details
Trial ID
NCT04304131
Start Date
June 7 2020
End Date
January 10 2022
Last Update
March 14 2023
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Busan Hangun Hospital
Busan, South Korea
2
Koo Hospital
Daegu, South Korea
3
Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea, 03722
4
Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine
Seoul, South Korea, 05278